Page last updated: 2024-10-17

creatine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

creatine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
" Muscle pain and elevation of serum creatine kinase (CK) occurred; thus, atorvastatin was replaced by ezetimibe."3.88Statin-induced myopathy prevented by creatine administration. ( Adriano, E; Balestrino, M, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balestrino, M1
Adriano, E1
Hino, A1
Yoshida, H1
Tada, Y1
Koike, M1
Minami, R1
Masaie, H1
Ishikawa, J1

Other Studies

2 other studies available for creatine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Statin-induced myopathy prevented by creatine administration.
    BMJ case reports, 2018, Aug-27, Volume: 2018

    Topics: Aged; Amaurosis Fugax; Anticholesteremic Agents; Carotid Stenosis; Cholesterol, LDL; Creatine; Drug

2018
Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.
    International journal of hematology, 2016, Volume: 104, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Creatine; Dasatinib; Glomerular Filtration Rate; Humans; Imatinib Me

2016